Eosinophilotactic Peptide
CAS No. 61756-22-7
Eosinophilotactic Peptide ( ——— )
Catalog No. M39922 CAS No. 61756-22-7
Val-Gly-Ser-Glu (NSC 350591) is an ECF-A tetrapeptide. Val-Gly-Ser-Glu dose-dependently increases the number of human eosinophils, but not neutrophils, rosetting with complement-coated sheep erythrocytes (EAC3b).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEosinophilotactic Peptide
-
NoteResearch use only, not for human use.
-
Brief DescriptionVal-Gly-Ser-Glu (NSC 350591) is an ECF-A tetrapeptide. Val-Gly-Ser-Glu dose-dependently increases the number of human eosinophils, but not neutrophils, rosetting with complement-coated sheep erythrocytes (EAC3b).
-
DescriptionVal-Gly-Ser-Glu (NSC 350591) is an ECF-A tetrapeptide. Val-Gly-Ser-Glu dose-dependently increases the number of human eosinophils, but not neutrophils, rosetting with complement-coated sheep erythrocytes (EAC3b).
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number61756-22-7
-
Formula Weight390.4
-
Molecular FormulaC15H26N4O8
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Anwar AR, et al. The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors. Nature. 1977 Oct 6;269(5628):522-4.?
molnova catalog
related products
-
6''-O-xylosyl-glycit...
6''-O-xylosyl-glycitin is isolated from the flower of Pueraria thunbergiana Benth.
-
Neuropeptide S (huma...
Neuropeptide S human (TFA) is a potent endogenous neuropeptide S receptor agonist (EC50=9.4 nM).
-
Perflexane
Perflexane was developed as an ultrasound contrast agent.
Cart
sales@molnova.com